Monitoring of coagulation during treatment with direct oral anticoagulants

被引：2
作者：
Kasper, A. [1 ]
Lindhoff-Last, E. [1 ]
机构：
[1] Univ Frankfurt Klinikum, Schwerpunkt Angiol Hamostaseol, D-60590 Frankfurt, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2013年 / 138卷 / 40期
关键词：
direct oral anticoagulants; DOAC; Monitoring; apixaban; dabigatran; rivaroxaban; ASSAYS LABORATORY RECOMMENDATIONS; DIRECT THROMBIN INHIBITOR; DABIGATRAN; IMPACT; ROUTINE;
D O I：
10.1055/s-0033-1349526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1997 / 2000
页数：4
相关论文
共 50 条
  • [31] Laboratory Assessment of Direct Oral Anticoagulants
    Douxfils, Jonathan
    Gosselin, Robert C.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03) : 277 - 290
  • [32] Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests
    Giuseppe Lippi
    Diego Ardissino
    Roberto Quintavalla
    Gianfranco Cervellin
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 269 - 274
  • [33] The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy
    Masotti, Luca
    Landini, Giancarlo
    Panigada, Grazia
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 48 - 58
  • [34] Direct oral anticoagulants in point-of-care monitoring: an ex-vivo study
    Klages, Matthias
    Raimann, Florian J.
    Philipp, Anna-Lena
    Lindhoff-Last, Edelgard
    Zacharowski, Kai
    Mutlak, Haitham
    MINERVA ANESTESIOLOGICA, 2021, 87 (05) : 514 - 522
  • [35] Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know
    Conway, Susan E.
    Hwang, Andrew Y.
    Ponte, Charles D.
    Gums, John G.
    PHARMACOTHERAPY, 2017, 37 (02): : 236 - 248
  • [36] Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
    Gilyarevsky, S. R.
    Vereina, N. K.
    Golshmid, M. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (03) : 290 - 297
  • [37] Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism
    Lim, Hui Yin
    Nandurkar, Harshal
    Ho, Prahlad
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (03) : 261 - 266
  • [38] Direct oral anticoagulants for treatment of venous thrombosis: illustrated review of appropriate use
    Khairani, Candrika D.
    Bejjani, Antoine
    Assi, Ali
    Porio, Nicole
    Talasaz, Azita H.
    Piazza, Gregory
    Cushman, Mary
    Bikdeli, Behnood
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [39] Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants
    Loeser, C.
    Nast, A.
    Zeymer, U.
    HAUTARZT, 2019, 70 (11): : 850 - 853
  • [40] Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants
    Schmitz, E. M. H.
    Boonen, K.
    van den Heuvel, D. J. A.
    van Dongen, J. L. J.
    Schellings, M. W. M.
    Emmen, J. M. A.
    van der Graaf, F.
    Brunsveld, L.
    van de Kerkhof, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (10) : 1636 - 1646
12345